286 related articles for article (PubMed ID: 25746737)
1. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films.
Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ
Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737
[TBL] [Abstract][Full Text] [Related]
2. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
[TBL] [Abstract][Full Text] [Related]
3. Outlining critical quality attributes (CQAs) as guidance for the development of orodispersible films.
Borges AF; Silva C; Coelho JF; Simões S
Pharm Dev Technol; 2017 Mar; 22(2):237-245. PubMed ID: 27346557
[TBL] [Abstract][Full Text] [Related]
4. Quality by Design approach for studying the impact of formulation and process variables on product quality of oral disintegrating films.
Mazumder S; Pavurala N; Manda P; Xu X; Cruz CN; Krishnaiah YSR
Int J Pharm; 2017 Jul; 527(1-2):151-160. PubMed ID: 28549972
[TBL] [Abstract][Full Text] [Related]
5. Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.
Cupone IE; Dellera E; Marra F; Giori AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322282
[TBL] [Abstract][Full Text] [Related]
6. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
7. Original research paper. Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach.
Gavan A; Porfire A; Marina C; Tomuta I
Acta Pharm; 2017 Mar; 67(1):53-70. PubMed ID: 28231048
[TBL] [Abstract][Full Text] [Related]
8. Effect of plasticizers on the physico-mechanical properties of pullulan based pharmaceutical oral films.
Vuddanda PR; Montenegro-Nicolini M; Morales JO; Velaga S
Eur J Pharm Sci; 2017 Jan; 96():290-298. PubMed ID: 27629498
[TBL] [Abstract][Full Text] [Related]
9. Characterization and optimization of orodispersible mosapride film formulations.
ElMeshad AN; El Hagrasy AS
AAPS PharmSciTech; 2011 Dec; 12(4):1384-92. PubMed ID: 22009305
[TBL] [Abstract][Full Text] [Related]
10. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
Speer I; Lenhart V; Preis M; Breitkreutz J
Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
[TBL] [Abstract][Full Text] [Related]
11. Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach.
Chudiwal VS; Shahi S; Chudiwal S
Drug Dev Ind Pharm; 2018 May; 44(5):787-799. PubMed ID: 29198152
[TBL] [Abstract][Full Text] [Related]
12. Application of simplex lattice design and desirability function for the formulation development of mouth dissolving film of salbutamol sulphate.
Gohel MC; Parikh RK; Aghara PY; Nagori SA; Delvadia RR; Dabhi MR
Curr Drug Deliv; 2009 Oct; 6(5):486-94. PubMed ID: 19863489
[TBL] [Abstract][Full Text] [Related]
13. Formulation Optimization and in Vitro Characterization of Orally Disintegrating Films Using a Factorial Design and Mathematical Modeling for Drug Release.
Lee Y; Thapa P; Jeong SH; Woo MH; Choi DH
Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):166-177. PubMed ID: 27904030
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobic polymers for orodispersible films: a quality by design approach.
Borges AF; Silva BM; Silva C; Coelho JF; Simões S
Expert Opin Drug Deliv; 2016 Oct; 13(10):1357-74. PubMed ID: 27466880
[TBL] [Abstract][Full Text] [Related]
15. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
16. STUDY OF DUAL MATRIX TABLETS CONTAINING HYPROMELLOSE OF DIFFERENT VISCOSITY DEGREE AND GLYCERYL DIBEHENATE.
Mužíková J; Holubová K; Komersová A; Lochar V
Acta Pol Pharm; 2016; 73(2):461-8. PubMed ID: 27180439
[TBL] [Abstract][Full Text] [Related]
17. Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution.
Krull SM; Patel HV; Li M; Bilgili E; Davé RN
Eur J Pharm Sci; 2016 Sep; 92():146-55. PubMed ID: 27402100
[TBL] [Abstract][Full Text] [Related]
18. Disintegration time of orally dissolving films: various methodologies and
Saab M; Mehanna MM
Pharmazie; 2019 Apr; 74(4):227-230. PubMed ID: 30940306
[TBL] [Abstract][Full Text] [Related]
19. "Real-time" disintegration analysis and D-optimal experimental design for the optimization of diclofenac sodium fast-dissolving films.
El-Malah Y; Nazzal S
Pharm Dev Technol; 2013; 18(6):1355-60. PubMed ID: 22780708
[TBL] [Abstract][Full Text] [Related]
20. Fast dissolving films made of maltodextrins.
Cilurzo F; Cupone IE; Minghetti P; Selmin F; Montanari L
Eur J Pharm Biopharm; 2008 Nov; 70(3):895-900. PubMed ID: 18667164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
